interleukin-17 serum levels and tlr4 polymorphisms in ulcerative colitis
Authors
abstract
background: inflammatory bowel disease, an autoimmune disease, has two clinical manifestations including crohn’s disease and ulcerative colitis (uc). il-17 has been the target of intensive research in autoimmune diseases. the influence of toll like receptor 4 (tlr-4) gene polymorphisms on il-17 production has also been revealed in uc patients and tissue inflammation in mice. objectives: to investigate the association between the tlr-4 gene polymorphisms, asp299gly and thr399ile and il-17 serum levels with ulcerative colitis. additionally, we aimed to study modulation effects of forenamed gene polymorphisms on il-17 serum levels in uc patients and controls. methods: a total of 256 healthy controls and 85 uc patients enrolled in our study. dna was extracted and pcr-rflp technique was employed to determine asp299gly and thr399ile polymorphisms in tlr-4 gene and il-17 serum levels were measured by elisa method. results: there was no significant difference between the frequency of asp299gly a>g and thr399ile c>t in uc patients and controls. while il-17 serum levels in uc patients were significantly higher than controls (p=0.003), no significant difference in il-17 levels between different genotypes existed. additionally, a significant inverse relationship was observed between hemoglobin level and il-17 serum levels in uc patients (p=0.039). conclusions: increased il-17 serum levels in our uc patients might be explained through the synergistic activity of il-17/il-23 axis and pro-inflammatory cytokines, causing severe clinical outcome in patients with ibd. the prolonged excretion of blood in stool driven by inflammatory process which causes iron metabolism disorder and anemia may elucidate the inverse correlation between hemoglobin and il-17 serum levels in uc patients. lack of association between the tlr-4 gene polymorphisms and uc in our study was consistent with the results from other caucasian populations.
similar resources
Interleukin-17 Serum Levels and TLR4 Polymorphisms in Ulcerative Colitis
Background: Inflammatory bowel disease, an autoimmune disease, has two clinical manifestations including Crohn’s disease and ulcerative colitis (UC). IL-17 has been the target of intensive research in autoimmune diseases. The influence of Toll like receptor 4 (TLR-4) gene polymorphisms on IL-17 production has also been revealed in UC patients and tissue inflammation in mice. Objectives: To inve...
full textInterleukin-17 serum levels and TLR4 polymorphisms in ulcerative colitis.
BACKGROUND Inflammatory bowel disease, an autoimmune disease, has two clinical manifestations including Crohn's disease and ulcerative colitis (UC). IL-17 has been the target of intensive research in autoimmune diseases. The influence of Toll like receptor 4 (TLR-4) gene polymorphisms on IL-17 production has also been revealed in UC patients and tissue inflammation in mice. OBJECTIVES To inve...
full textSerum Interleukin-23 Levels in Patients with Ulcerative Colitis
Background: Patients with ulcerative colitis are at increased risk of inflammation. Interleukin 23 (IL-23) is a newly identified cytokine with increased expression in inflamed biopsies of colon mucosa in patients with Crohn's disease; however, there is inconsistent evidence on its role in ulcerative colitis. Objective: We aimed to compare serum IL-23 level in patients with ulcerative colitis an...
full textSerum interleukin-23 levels in patients with ulcerative colitis.
BACKGROUND Patients with ulcerative colitis are at increased risk of inflammation. Interleukin 23 (IL-23) is a newly identified cytokine with increased expression in inflamed biopsies of colon mucosa in patients with Crohn's disease; however, there is inconsistent evidence on its role in ulcerative colitis. OBJECTIVE We aimed to compare serum IL-23 level in patients with ulcerative colitis an...
full textSerum Complement Levels in Active Ulcerative Colitis.
The present study was originally stimulated by Long's (1963) observations on patients with burns. Many patients became ill with a pyrexia 10 to 14 days after burning and often this illness could not be explained by infection. Long found very low serum complement levels in these patients and produced a striking clinical improvement by transfusing fresh defibrinated blood which restored complemen...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of immunologyجلد ۱۰، شماره ۲، صفحات ۸۳-۹۲
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023